Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 241,900.00%19.36M | -97.60%191K | -99.90%8K | -86.78%7.95M | -77.55%7.84M | -93.39%60.14M | -96.00%34.94M | -42.59%910.33M | 35.78%872.42M | 57.06%1.59B |
| Operating income | 241,900.00%19.36M | -97.60%191K | -99.90%8K | -86.78%7.95M | -77.55%7.84M | -93.39%60.14M | -96.00%34.94M | -42.59%910.33M | 35.78%872.42M | 57.06%1.59B |
| Cost of sales | ---16.61M | ---2.53M | ---- | ---- | ---- | ---- | ---- | ---- | -39.93%-829.04M | ---- |
| Other costs | ---- | ---- | ---- | 84.24%-7.65M | 41.66%-7.57M | 94.44%-48.53M | 31.14%-12.97M | 41.90%-873.1M | -63.80%-18.83M | -66.41%-1.5B |
| Operating expenses | -16.61M | 66.94%-2.53M | 84.24%-7.65M | 41.66%-7.57M | 94.44%-48.53M | 98.47%-12.97M | 41.90%-873.1M | -40.38%-847.87M | -66.41%-1.5B | |
| Gross profit | 2.75M | -871.62%-2.34M | -97.39%303K | -98.73%279K | -68.81%11.61M | -10.49%21.97M | -54.97%37.23M | -36.32%24.55M | -22.27%82.68M | |
| Selling expenses | ---- | ---- | ---- | ---- | ---- | ---- | -1.67%-122K | 42.96%-235K | 51.42%-120K | 45.86%-412K |
| Research and development expenses | ---- | ---6.63M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Employee expense | -107.88%-9.07M | -167.02%-11.3M | -83.94%-4.36M | 43.70%-4.23M | 77.80%-2.37M | 68.99%-7.51M | 6.29%-10.69M | 18.71%-24.23M | 28.27%-11.4M | 39.57%-29.8M |
| Depreciation and amortization | ---- | 70.58%-681K | ---- | -9.56%-2.32M | 78.83%-1.22M | 84.03%-2.11M | 16.39%-5.74M | 37.58%-13.23M | 44.25%-6.87M | 45.99%-21.19M |
| Revaluation surplus | --960K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Changes in the fair value of other assets | --960K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provision | 101.74%23K | 54.36%-17.03M | ---1.32M | -676.16%-37.31M | ---- | -372.66%-4.81M | ---- | 80.81%-1.02M | 177.06%467K | 61.52%-5.3M |
| -Impairment of intangible assets | ---- | ---- | ---- | ---4.66M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 94.96%-36K | ---- | 39.59%-714K |
| -Goodwill impairment | ---- | ---- | ---- | ---8.81M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | 101.74%23K | 28.56%-17.03M | ---1.32M | -395.92%-23.84M | ---- | -390.01%-4.81M | ---- | 78.61%-981K | 197.09%467K | 63.57%-4.59M |
| Operating interest expense | -139.67%-676K | ---- | --1.7M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items of operating profit | -70.10%-7.33M | 21.15%-8.86M | 35.23%-4.31M | 0.50%-11.24M | 45.43%-6.66M | 52.30%-11.3M | 5.37%-12.2M | 14.64%-23.68M | 4.50%-12.89M | 20.13%-27.74M |
| Operating profit | -61.18%-13.35M | 14.53%-46.83M | 16.90%-8.28M | -288.13%-54.79M | -47.08%-9.97M | 43.88%-14.12M | -8.12%-6.78M | -1,320.50%-25.16M | -55.79%-6.27M | 94.37%-1.77M |
| Financing income | ---- | -14.96%3.16M | ---- | 44.59%3.72M | 65.88%1.9M | 66.45%2.57M | 148.05%1.15M | 12.62%1.54M | 178.17%462K | 281.59%1.37M |
| Share of profits of associates | -6.86%-4.6M | -35.12%-17.81M | -33.46%-4.3M | -206.00%-13.18M | -3,111.21%-3.22M | 39.12%12.44M | -96.97%107K | -48.84%8.94M | -13.96%3.53M | 399.60%17.48M |
| Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | 23.33%2.15M | -39.01%9.96M | -72.60%1.74M | 99.87%16.33M |
| Earning before tax | -42.61%-17.94M | 4.32%-61.49M | -11.47%-12.58M | -7,320.11%-64.26M | -234.30%-11.29M | 118.88%890K | -527.51%-3.38M | -114.12%-4.72M | -108.35%-538K | 262.61%33.4M |
| Tax | 854.03%3.2M | -73.63%746K | -39.53%335K | 141,550.00%2.83M | 75.87%554K | 99.85%-2K | 240.00%315K | 83.05%-1.34M | 59.53%-225K | -1,744.86%-7.9M |
| After-tax profit from continuing operations | -20.41%-14.75M | 1.12%-60.74M | -14.11%-12.25M | -7,017.79%-61.43M | -250.60%-10.73M | 114.67%888K | -301.18%-3.06M | -123.73%-6.05M | -112.97%-763K | 221.64%25.51M |
| After-tax profit from non-continuing business | ---- | ---- | ---- | 1,234.65%25.64M | --25.64M | ---2.26M | ---- | ---- | ---- | ---- |
| Earning after tax | -20.41%-14.75M | -69.73%-60.74M | -182.13%-12.25M | -2,508.38%-35.79M | 587.13%14.91M | 77.33%-1.37M | -301.18%-3.06M | -123.73%-6.05M | -112.97%-763K | 221.64%25.51M |
| Minority shareholders should account for profits from continuing business | ---- | ---3.99M | ---- | ---- | ---- | ---9K | ---- | ---- | ---- | ---- |
| Minority profit | -279.96%-4.31M | ---3.99M | ---1.13M | ---- | ---- | 62.50%-9K | 18.18%-9K | 44.19%-24K | 57.69%-11K | -30.30%-43K |
| Shareholders should account for profits from continuing business | ---- | 7.61%-56.75M | ---- | -6,948.38%-61.43M | ---10.73M | --897K | ---- | ---- | ---- | ---- |
| Shareholders should account for profits from non-continuing business | ---- | ---- | ---- | 1,234.65%25.64M | --25.64M | ---2.26M | ---- | ---- | ---- | ---- |
| Profit attributable to shareholders | 6.05%-10.44M | -58.59%-56.75M | -174.53%-11.11M | -2,525.61%-35.79M | 588.56%14.91M | 77.39%-1.36M | -305.85%-3.05M | -123.60%-6.03M | -112.72%-752K | 222.03%25.55M |
| Basic earnings per share | 11.29%-0.011 | -54.86%-0.0621 | -174.25%-0.0124 | -2,573.33%-0.0401 | 577.14%0.0167 | 78.57%-0.0015 | -288.89%-0.0035 | -123.57%-0.007 | -113.04%-0.0009 | 221.22%0.0297 |
| Diluted earnings per share | 11.29%-0.011 | -54.86%-0.0621 | -174.25%-0.0124 | -2,573.33%-0.0401 | 577.14%0.0167 | 78.57%-0.0015 | -288.89%-0.0035 | -123.57%-0.007 | -113.04%-0.0009 | 221.22%0.0297 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | ZTE Zheng Zheng Certified Public Accountants Co., Ltd. | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Rosenmei Certified Public Accountants | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.